Pfizer stock heads into the open after a 0.14% dip

Pfizer stock closed at USD 27.60 on the NYSE on September 18, 2026, down 0.14 percent from the prior session according to NYSE data cited by MarketBeat. The share price sat within its recent trading range while the Nasdaq Composite rose 0.39 percent that day, leaving Pfizer lagging the broader growth index.

September 18, 2026 in numbers

Pfizer Inc. (ISIN US7170811035, NYSE: PFE) finished the September 18, 2026 session at USD 27.60, having traded between an intraday low of USD 27.40 and a high of USD 27.77 per NYSE quote data reported by MarketBeat. The 0.14 percent decline came on a closing price that remains well below the stock's 52-week high, while the volume was close to recent averages, signaling measured trading interest rather than an outsized move.

Per the pricing overview at MarketBeat, Pfizer's USD 27.60 close on September 18, 2026 compared with a 0.39 percent gain for the Nasdaq Composite on the same day, underscoring that the stock underperformed major growth-oriented benchmarks in that session. The slight decline also left the shares still above their recent lows within the current 52-week range, suggesting the move was part of a broader consolidation rather than a sharp break in trend.

Today’s outlook for September 21, 2026

Heading into today’s US session on September 21, 2026, attention around Pfizer centers on how investors digest commentary that its major business headwinds are easing, as highlighted in a recent analysis from The Motley Fool. That piece pointed to expectations of a more stable earnings and dividend profile, which can shape sentiment for large pharmaceutical names when US markets reopen today. Broader market cues also matter, with the Nasdaq Composite’s gain on September 18, 2026 providing a supportive backdrop for risk assets, even as individual healthcare stocks such as Pfizer track their own news and pipeline developments over the coming sessions.